| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nkarta, Inc. (NKTX) has 11 insiders with recent SEC Form 4 filings, including 4 buys and 0 sells. NKTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 390.0K | $1.24M | - | |
| Pres | 167.7K | $535.0K | - | |
| Other | 139.0K | $443.4K | - | |
| Dir | 46.0K | $146.7K | - | |
| 10% | 46.0K | $146.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 14, 2020 | Florence Anthony A. Jr.57 | 10% Owner | Buy | 666,666 | $18.00 | $11,999,988.00 | +29.8% | |
| Jul 14, 2020 | Glaxosmithkline Plc | Director, 10% Owner | Buy | 833,333 | $18.00 | $14,999,994.00 | +36.0% | |
| Jul 14, 2020 | Ra Capital Management, L.P.52 | 10% Owner | Buy | 3,333,333 | $18.00 | $59,999,994.00 | +146.7% | |
| Jul 14, 2020 | Novo Holdings A/s58 | 10% Owner | Buy | 555,555 | $18.00 | $9,999,990.00 | +24.8% |